MedPath
FDA Approval

Neomycin and Polymyxin B Sulfates and Dexamethasone

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
June 1, 2012
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Dexamethasone(1 mg in 1 mL)
Neomycin(3.5 mg in 1 mL)
Polymyxin B(10000 [USP'U] in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Physicians Total Care, Inc.

Physicians Total Care, Inc.

194123980

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Neomycin and Polymyxin B Sulfates and Dexamethasone

Product Details

NDC Product Code
54868-1070
Application Number
ANDA062721
Marketing Category
ANDA (C73584)
Route of Administration
OPHTHALMIC
Effective Date
June 1, 2012
Code: 7S5I7G3JQLClass: ACTIBQuantity: 1 mg in 1 mL
NeomycinActive
Code: 057Y626693Class: ACTIMQuantity: 3.5 mg in 1 mL
Code: 19371312D4Class: ACTIMQuantity: 10000 [USP'U] in 1 mL
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7Class: IACT
HYPROMELLOSE 2910 (4000 MPA.S)Inactive
Code: RN3152OP35Class: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
POLYSORBATE 20Inactive
Code: 7T1F30V5YHClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath